Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Judith Baumeister
Observed name:
Baumeister, Judith
Institution:
Argenx (Belgium)
Observed institutions:
Ablynx (Belgium),
Janssen (Belgium),
Justus-Liebig-Universität Gießen,
GlaxoSmithKline (Belgium),
Argenx (Belgium),
AiCuris (Germany),
Bayer (Germany)
show all 7
OpenAlex ID:
A5111614201
New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease
2002
·
Gerald Kleymann
, Rüdiger Fischer
, et al.
·
Nature Medicine
·
357
In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
2010
·
Peter Lischka
, Guy Hewlett
, et al.
·
Antimicrobial Agents and Chemotherapy
·
262
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
2015
·
Maarten Van Roy
, Cedric Ververken
, et al.
·
Arthritis Research & Therapy
·
203
PDF
Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs
2011
·
Hans Ulrichts
, Karen Silence
, et al.
·
Blood
·
196
Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®
2015
·
Sven Hoefman
, Ingrid Ottevaere
, et al.
·
Antibodies
·
131
PDF
Pseudorabies Virus Glycoprotein gK Is a Virion Structural Component Involved in Virus Release but Is Not Required for Entry
1998
·
Barbara G. Klupp
, Judith Baumeister
, et al.
·
Journal of Virology
·
72
Superior Efficacy of Helicase-Primase Inhibitor BAY 57–1293 for Herpes Infection and Latency in the Guinea Pig Model of Human Genital Herpes Disease
2007
·
Judith Baumeister
, Ruediger Fischer
, et al.
·
Antiviral chemistry & chemotherapy
·
54
Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors
2012
·
Tim H.M. Jonckers
, Marie-Claude Rouan
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
38
In Vitro and In Vivo Activities of the Novel Anti-cytomegalovirus Compound AIC246
2010
·
Peter Lischka
, Guy Hewlett
, et al.
·
Antiviral Research
·
18
Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models
2025
·
Prajakta Warang
, Gagandeep Singh
, et al.
·
Human Vaccines & Immunotherapeutics
·
16
Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats
2021
·
Alan H. Stokes
, Kelle Franklin
, et al.
·
International Journal of Toxicology
·
13
Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys
2025
·
Ornella Binazon
, Mario Cocco
, et al.
·
Journal of Immunotoxicology
·
9
PDF
Translational population target binding model for the anti-FcRn fragment antibody efgartigimod
2024
·
Sven Hoefman
, Tamara van Steeg
, et al.
·
Journal of Pharmacokinetics and Pharmacodynamics
·
9
PDF
ALX-0962, an anti-IgE Nanobody® with a dual mode of action
2013
·
Manuela Rinaldi
, Tinneke Denayer
, et al.
·
European Respiratory Journal
·
9
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.
2009
·
Khalid Abd-Elaziz
, Pieter W. Kamphuisen
, et al.
·
Blood
·
6
Safety of Nanobody® ALX-0651 targeting the G protein coupled receptor CXCR4
2012
·
Sandra De Boever
, Sandy Jacobs
, et al.
·
Toxicology Letters
·
5
Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits
2020
·
Éric Destexhe
, Émilie Grosdidier
, et al.
·
Regulatory Toxicology and Pharmacology
·
3
ALX-0171 toxicity study in RSV-infected cotton rats: Safety and therapeutic potential
2012
·
Gilles Hanton
, Laurent Detalle
, et al.
·
Toxicology Letters
·
3
Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and Rats
2022
·
Alan H. Stokes
, Camille Planty
, et al.
·
International Journal of Toxicology
·
2
Nonclinical safety assessment of the RANK-L targeting Nanobody® ALX-0141
2012
·
Sandy Jacobs
, Maarten Van Roy
, et al.
·
Toxicology Letters
·
1
NON-CLINICAL SAFETY ASSESSMENT OF ALX-0171, a NANOBODY® INTENDED FOR CLINICAL ADMINISTRATION VIA NEBULISATION
2013
·
Erik Depla
, Koen Allosery
, et al.
Show more works
View as search
Works count:
24
Citation count:
1,407
H-index:
11
I10-index:
11
Year
Topic
Type